Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 55 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/23/16
End: 12/07/17
Due: 12/07/18
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 10/31/05
Due: 10/31/06
Phase: N/A
Priority: Normal
Start: 08/31/08
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 04/01/11
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 05/21/15
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 09/01/09
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 04/01/09
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 04/04/16
End: 03/20/20
Due: 03/20/21
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 10/31/14
End: -
Due: -
A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC
Phase: N/A
Priority: Normal
Start: 01/26/16
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 03/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/03
End: 01/31/08
Due: 01/31/09